Signal Transduction and Targeted Therapy 期刊简介
Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.
信号转导和靶向治疗 (ISSN 2059-3635 (在线),ISSN 2095-9907 (印刷),CN 51-1758/R) 是一种新的开放获取期刊,旨在及时发布与信号转导和靶向治疗相关的基础科学和临床研究的最新发现和进展。它将包括对人类主要疾病的研究,包括但不限于: 癌症,心血管疾病,自身免疫性疾病和神经系统疾病。
期刊ISSN
|
2095-9907 |
影响指数
|
18.005 |
最新CiteScore值
|
12.90 查看CiteScore评价数据 |
最新自引率
|
1.60% |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
期刊加急投稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW |
偏重的研究方向(学科)
|
Biochemistry, Genetics and Molecular Biology-Genet |
出版周期
|
|
出版年份
|
2016 |
出版国家/地区
|
United Kingdom |
是否OA
|
Yes |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
BIOCHEMISTRY & MOLECULAR BIOLOGY(生化与分子生物学)1区
CELL BIOLOGY(细胞生物学)1区
否
|
|||||
最新的影响因子
|
18.005 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 0 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
12.90
|
||||||||||||||
年文章数 | 143 | ||||||||||||||
SJR
|
4.284 | ||||||||||||||
SNIP
|
4.279 | ||||||||||||||
CiteScore排名
|
|
||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
Lancet Gastroenterology & Hepatology | 18.301 |
Lancet Public Health | 21.432 |
Nature Human Behaviour | 13.526 |
Applied Materials Today | 9.941 |
Gut Microbes | 10.143 |
Additive Manufacturing | 10.888 |
Virtual and Physical Prototyping | 8.011 |
Liver Cancer | 11.623 |
Signal Transduction and Targeted Therapy | 18.005 |
分享者 | 点评内容 |